论文部分内容阅读
通过一项多中心前瞻性观察性研究,比较万古霉素和替考拉宁治疗卫生保健相关耐甲氧西林金黄色葡萄球菌(HAMRSA)菌血症的疗效以及安全性。在2010年2月—2011年7月韩国15所教学医院中,18岁以上HA-MRSA菌血症患者190例,其中接受万古霉素治疗者134例,接受替考拉宁治疗者56例。起始24 h或36 h内,予起始剂量万古霉素1 g每12小时1次或替考拉宁400 mg每12小时1次,继以
In a multicenter prospective observational study, the efficacy and safety of vancomycin and teicoplanin in the treatment of hyme disease associated with methicillin-resistant Staphylococcus aureus (HAMRSA) in health care were compared. In February 2010-July 2011 in South Korea 15 teaching hospitals, 18 patients over the age of HA-MRSA bacteremia in 190 cases, of which received vancomycin in 134 cases, 56 cases received teicoplanin treatment. Within 24 h or 36 h of the start-up dose of vancomycin 1 g every 12 hours or teicoplanin 400 mg every 12 hours, followed by